Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #142546 on Biotech Values
NP1986
05/24/12 5:12 PM
#142551 RE: DewDiligence #142546
In this study, healthy male volunteers will receive a single intravenous administration of either PF-05280014 or trastuzumab (United States) or trastuzumab (European Union)
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads